Lower Treatment Cost Doesn't Mean Lower Quality Care

As health care facilities across the country are finding ways to cut costs without sacrificing quality care, the Memorial Sloan-Kettering Cancer Center decided not to offer the drug ziv-aflibercept (Zaltrap) for the treatment of colorectal cancer.

At the eighth annual Chicago Supportive Oncology Conference, Dr. Thomas Smith said the center's decision could be a game-changer. Meanwhile, Dr. Anthony Back stressed the importance of talking to patients about cost of treatment.

As health care facilities across the country are finding ways to cut costs without sacrificing quality care, the Memorial Sloan-Kettering Cancer Center decided not to offer the drug ziv-aflibercept (Zaltrap) for the treatment of colorectal cancer.

At the eighth annual Chicago Supportive Oncology Conference, Dr. Thomas Smith said the center's decision could be a game-changer. Meanwhile, Dr. Anthony Back stressed the importance of talking to patients about cost of treatment.

As health care facilities across the country are finding ways to cut costs without sacrificing quality care, the Memorial Sloan-Kettering Cancer Center decided not to offer the drug ziv-aflibercept (Zaltrap) for the treatment of colorectal cancer.

At the eighth annual Chicago Supportive Oncology Conference, Dr. Thomas Smith said the center's decision could be a game-changer. Meanwhile, Dr. Anthony Back stressed the importance of talking to patients about cost of treatment.